A carregar...

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults

BACKGROUND: Viloxazine extended-release is a novel nonstimulant under investigation as a potential treatment for attention-deficit/hyperactivity disorder (ADHD). Given the potential for viloxazine extended-release to be co-administered with stimulant ADHD pharmacotherapies, this trial investigated t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919699/
https://ncbi.nlm.nih.gov/pubmed/33587403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001361
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!